Oxford Cannabinoid interim loss nearly doubles as research costs surge
Oxford Cannabinoid Technologies Holdings PLC on Monday reported a widened half-year loss as research costs ballooned.
Oxford Cannabinoid is a cannabinoid medicines-focused pharmaceutical firm. Its...
Mon, 23/01/2023 - 14:17